Optofluidic chip platform developed for single molecule analysis
A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.
List view / Grid view
A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.
Designing new drug molecules is crucial to R&D. Dr Sam Genway suggests that one way to improve and speed up this process is using AI inspired by language translation.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Molecular Devices, LLC, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.
A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.
Using human data, a new study has examined how Cryptococcus genes impact patients with Cryptococcus Neoformans.
Researchers have developed a chip which facilitates and accelerates active substance production, characterisation and biological effectiveness.
A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
A new study has identified antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood.
Progressing drug discovery projects to a stage that attracts commercial interest is a challenging endeavour, evidenced by the fact that only a small proportion of drug discovery projects are successfully progressed to such a stage. A major cause of this is the lack of comprehensive profiling of compounds prior to…
Scientists have discovered a cell intrinsic tumour suppressor role of the innate immune sensor Toll-like receptor 2.
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.